Caplin Point Laboratories has received EU GMP approval for its small volume sterile injectable liquids facility at Chennai. The site was inspected by the EU authorities in March 2015 and has been certified as compliant with the guidelines. The facility is capable of manufacturing Liquid Injectables in Vials, Ampoules, Lyophilized Vials and Opthalmic dosages.
EU approval grants access not only to the European Union, but also several other countries in the Regulated domain through mutual recognition process.
Caplin Point Laboratories is a niche pharmaceutical company with a unique business model catering predominantly to emerging markets of Latin America and Africa.
